-- Market Chatter- Corporate finance press digest
-- 
-- Mon Jun 02, 2014 12:02AM EDT
-- None



June 2 (Reuters) - The following corporate finance-related stories were reported by media:

* Japanese insurer Dai-ichi Life Co <8750.T> is in advanced talks to buy Protective Life Corp <PL.N> of the United States in a deal that could be worth over $5 billion, a source with direct knowledge of the matter said on Monday. [ID:nL3N0OI0QM]  * Canadian equipment finance company Element Financial Corp <EFN.TO> is close to a deal to buy PHH Corp's <PHH.N> auto fleet leasing business for about $1.35 billion in cash, two sources familiar with the matter said on Friday. [ID:nL1N0OG1DA]  * U.S. private equity firm Catterton Partners is close to acquiring control of John Hardy after holding exclusive talks with the Bali-inspired jeweller for more than a month, sources close to the matter told Reuters. [ID:nL6N0OG3YZ]  * Australian private equity giant Pacific Equity Partners plans to follow the country's biggest market listing of the year with its second biggest, saying it wants to raise up to A$690 million ($642 million) by listing tampon and toilet paper maker Asaleo Care Ltd. [ID:nL3N0OJ0I9]  * The owners of German firm Rocket Internet aim to list the venture capital company behind online brands such as retailer Zalando for a market valuation of up to 5 billion euros ($6.8 billion), the Financial Times reported on Saturday online. [ID:nL6N0OH0EO]  * GlaxoSmithKline Plc <GSK.L> has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday. [ID:nL3N0OI0U0]  * Chinese e-commerce giant Alibaba Group Holding Ltd <IPO-ALIB.N> is one of several companies that are in talks to invest for a stake in U.S.-based advertising technology firm AppNexus, the Wall Street Journal said, citing sources familiar with the matter. [ID:nL3N0OG4PR]  * London-listed drugmaker Shire Plc <SHP.L> has secured a $5 billion credit facility for a takeover offer for New-Jersey-based NPS Pharmaceuticals <NPSP.O>, The Times of London reported on Sunday. [ID:nL3N0OI0HK]  For the deals of the day click on [DEALS/]